Molecular biology

mRNA Sequencing

Sequence identity is determined for mRNA raw materials and final products (vaccines and therapeutics) using Sanger sequencing following reverse transcription. The obtained sequence is subsequently compared with the respective reference sequence.

Product-specific methods are validated in accordance with ICH Q2 (R2), and the validated methods are subsequently implemented for routine testing.

Your contacts on this topic

We would be pleased to advise you and prepare an individual quotation for you! For more information and enquiries, please contact our team of experts:

Tina Börner

Molecular Biology
+49 9708 9100-232
tina.boerner@labor-ls.de

Viktoria Weidinger

Molecular Biology
+49 9708 9100-924
viktoria.weidinger@labor-ls.de